For media inquiries, please contact Michael Chancley, Communications and Mobilization Manager at [email protected]. FOR IMMEDIATE RELEASE: New York, NY, January 13, 2026–PrEP4All and the PrEP Users Union welcome the news that Gilead Sciences and CVS Caremark have finally reached a deal to include lenacapavir (brand name Yeztugo), a groundbreaking six-month injectable version of PrEP, on […]
PrEP4All’s PrEP Users’ Union and Positively Aware have collaborated on a series of articles written by PrEP users, providers, and advocates to shine a light on access challenges and solutions domestically and globally. Check out the whole series: Introduction: PrEP users lead advocacy toward access Facing unprecedented threats against HIV prevention, it’s vital that PrEP […]
In case you missed it, PrEP4All hosted an Mpox Update facilitated by Maxx Boykin featuring panelists: Monica Gandhi MD, MPH is a Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). Andy Seale is an adviser in the WHO department […]